5T4 (trophoblast glycoprotein) / TRBV7-9 T-cell receptor

Assets acting on this target.

Class
Tumor-targeted superantigen fusion protein (5T4 antibody fragment fused to engineered superantigen SEA/E-120; naptumomab estafenatox)
Pathway
5T4-antibody moiety anchors the fusion protein to tumor cells; the superantigen moiety selectively engages TRBV7-9-expressing cytotoxic T lymphocytes to trigger tumor cell killing

Related mechanisms

← all mechanisms